Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs

Cardiovasc Hematol Disord Drug Targets. 2018;18(2):83-85. doi: 10.2174/1871529X1802180628114731.

Authors

Konstantinos P Imprialos¹, Konstantinos Stavropoulos¹, Michael Doumas^{1

2}

Affiliations

¹ 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
² Veterans Affairs Medical Center, George Washington University, Washington, DC, United States.

PMID: 30009694
DOI: 10.2174/1871529X1802180628114731

No abstract available

Publication types

Editorial

MeSH terms

Cardiovascular Agents / pharmacology
Cardiovascular Agents / therapeutic use*
Diabetes Mellitus / drug therapy*
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use*
Sodium-Glucose Transporter 2 Inhibitors / pharmacology
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*

Substances

Cardiovascular Agents
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors